Esomeprazole Sodium (Akorn, Inc.)


Welcome to the PulseAid listing for the Esomeprazole Sodium drug offered from Akorn, Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Esomeprazole Sodium
SUBSTANCE NAME: ESOMEPRAZOLE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-03-06
END MARKETING DATE: 0000-00-00


Esomeprazole Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEsomeprazole Sodium from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/5mL)
START MARKETING DATE: 2017-03-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-850_8781d2f0-687a-41d0-bdfc-7c05acb0b42c
PRODUCT NDC: 17478-850
APPLICATION NUMBER: ANDA207181

Other ESOMEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Esomeprazole sodium
Akorn, Inc.Esomeprazole Sodium
AstraZeneca Pharmaceuticals LPNEXIUM
AuroMedics Pharma LLCEsomeprazole Sodium
Cardinal HealthNEXIUM
Sun Pharma Global FZEEsomeprazole Sodium
Sun Pharmaceutical Industries LimitedEsomeprazole Sodium